Coronavirus vaccine trial administers first dose to participant
A novel coronavirus vaccine trial in the US has now given a dose to its first participant, the National Institute of Allergy and Infectious Diseases announced Monday. The study aims to enroll a total of 45 healthy adults over a six-week time frame. Each participant will receive […]
Recent Comments